Corcym
- Company typePrivate
- Founded2021
- HeadquartersLondon, United Kingdom
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
Corcym firmographics
Firmographics- Name
- Corcym
- Legal name
- Corcym S.r.l.
- Website
- https://corcym.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Ownership category
- akta.pro rank
Corcym industry classification
Industry- Product category
- Cardiovascular Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Structural Heart Valves (TAVR/SAVR) & Valve Repair (HLAHAFAB)
- akta.pro secondary industry
- Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts) (HLAHAFAH)
Keywords
Where Corcym is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices4 records
Markets served
Corcym business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
Revenue model
- Medical Device Sales: Corcym generates revenue through the sale of surgical heart valve prostheses, repair devices, and minimally invasive cardiac surgery instruments. The company offers a comprehensive portfolio including sutureless valves, mechanical valves, annuloplasty rings, and related surgical instruments to cardiac surgeons and hospitals worldwide.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels8 records
Corcym product offering
Product offeringCore offering
Corcym designs, manufactures, and sells surgical solutions for structural heart disease, including sutureless aortic valves (Perceval Platform and Perceval Plus LANCELOT), mechanical aortic valves, mitral and aortic annuloplasty repair devices (Memo 4D and HAART), and minimally invasive cardiac surgery instruments (Miami Instruments). The company also provides a CT scan reading service using 3mensio software for pre-operative planning and a professional education program (Corcym Academy) for cardiac surgeons.
Product overview
Corcym is a global medical device company offering a comprehensive portfolio of surgical solutions for structural heart disease. The product portfolio centers on the Perceval Platform — the only truly sutureless surgical aortic valve available — alongside mechanical aortic valve replacements, the Memo 4D mitral annuloplasty ring, and HAART aortic annuloplasty devices for repair. The company also provides Miami Instruments for minimally invasive cardiac surgery, a CT scan reading service using 3mensio software for pre-operative planning, and Corcym Academy for professional surgeon education. Supporting services include a device tracking system for regulatory compliance and an Investigator Initiated Research program. The portfolio spans aortic and mitral/tricuspid repair and replacement solutions, with clinical evidence supported by studies including MANTRA.
Differentiator
Problem solved
Functional benefit
Brands
- Perceval Platform: Sutureless surgical aortic valve platform for aortic valve replacement
- Memo 4D
- HAART
- Corcym Academy
- MANTRA Study
- Corcym Device Tracking System
Products and services
- Perceval Sutureless Aortic Heart Valve Platform Sutureless aortic valve platform featuring a collapsible biological valve design that simplifies surgical implantation, reduces surgical impact, and facilitates faster patient recovery. The only truly sutureless surgical valve available on the market, with the next-generation Perceval Plus LANCELOT featuring precision laser-cut bovine pericardial leaflets. Used by cardiac surgeons in aortic valve replacement procedures in hospitals worldwide.
- HAART Aortic Annuloplasty Devices Aortic annuloplasty devices designed for aortic valve repair, with dedicated sessions available for trileaflet, bileaflet, and congenital pathologies. Used by cardiac surgeons for aortic valve repair procedures.
- Memo 4D Mitral Annuloplasty Ring
- Mechanical Aortic Valves
- Miami Instruments for Minimally Invasive Cardiac Surgery
- CT Scan Reading Service
- Corcym Academy Professional Education Program
Quantifiable outcome
- 75,000+ patients implanted with 13 years of clinical results demonstrating excellent outcomes
- +2 more outcomes
Companies that use Corcym
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles2 records
Corcym technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Corcym partnerships and signals
Strategic signalScale indicators7 records
Recent moves7 records
Expansion highlights6 records
Corcym competitors and assessment
Company assessmentBroad incumbents
- Edwards Lifesciences: Edwards Lifesciences is the global leader in structural heart disease, with the leading TAVR franchise (SAPIEN) and surgical valve portfolio. It is the most important competitor Corcym faces in aortic valve replacement and the reference point for the structural heart market in which Corcym operates.
- Medtronic: Medtronic offers a broad cardiovascular portfolio including surgical heart valves, TAVR (Evolut), and cardiac surgery devices. Its scale, global sales force, and full structural heart offering make it a direct competitor across Corcym's surgical valve and repair categories.
- Abbott: Abbott competes in structural heart through its Tendyne TMVR system and other cardiovascular devices, plus it has a large hospital sales channel. Its growing presence in structural heart overlaps directly with Corcym's target market of cardiac surgeons and hospitals.
- Boston Scientific: Boston Scientific has a growing cardiovascular and structural heart presence (including the ACURATE TAVR platform acquired from Symetis). Its global hospital sales force and broad device portfolio position it as a structural heart incumbent competing with Corcym for hospital contracts.
Direct peers
- LivaNova: LivaNova PLC was the parent of the heart valve business from which Corcym was carved out in 2021. While LivaNova has since divested this segment, it shares deep operational, clinical, and product heritage with Corcym and represents the most direct historical predecessor in surgical heart valves.
- Artivion: Artivion (formerly CryoLife) is a specialist in tissue heart valves (including the On-X mechanical valve) and cardiac repair products. It is a direct competitor in surgical heart valve replacement and repair, serving the same cardiac surgery customer base as Corcym.
Emerging players
- JenaValve Technology: JenaValve is an emerging structural heart company developing transcatheter aortic valve repair devices (Align JAV) for aortic regurgitation. It competes in the broader structural heart disease market and represents a next-generation entrant in the same therapeutic area as Corcym.
- MicroPort Scientific: MicroPort has a cardiovascular franchise in emerging markets including heart valves and interventional cardiology devices. Its strong Asia-Pacific presence and surgical valve portfolio make it a peer in the structural heart surgery category, with overlap in growth markets.
Regional players
- Meril Life Sciences: Meril Life Sciences is an India-based medical device company with a structural heart valve portfolio (including the MyVal TAVR and surgical valves). It is a regional competitor to Corcym in emerging markets, with comparable surgical heart valve products.
Others
- AtriCure: AtriCure is a cardiac surgery company focused on atrial fibrillation and left atrial appendage management, serving the same cardiac surgeon customer base as Corcym. While not a direct valve competitor, it is an adjacent specialty device company that competes for hospital capital and surgeon attention.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Corcym social profiles
Digital presenceCorcym compliance and trust
Trust signalCompliance3 records
Corcym financial estimates
Financial estimateRevenue estimate
Valuation estimate
Corcym leadership team
Management profileNumber of profiles
Profiles15 records
Corcym subsidiaries and ownership
Company hierarchySubsidiaries2 records
Corcym funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Corcym M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Corcym
What does Corcym do?
Corcym designs, manufactures, and sells surgical solutions for structural heart disease, including sutureless aortic valves (Perceval Platform and Perceval Plus LANCELOT), mechanical aortic valves, mitral and aortic annuloplasty repair devices (Memo 4D and HAART), and minimally invasive cardiac surgery instruments (Miami Instruments). The company also provides a CT scan reading service using 3mensio software for pre-operative planning and a professional education program (Corcym Academy) for cardiac surgeons.
Is Corcym a public or private company?
Corcym is a private company. It is classified as private equity controlled and is currently operating.
When was Corcym founded?
Corcym was founded in 2021. It employs 501 to 1,000 people.
Where is Corcym based?
Corcym is headquartered in London, United Kingdom, in the Europe region.
How does Corcym make money?
One revenue line is on record: medical Device Sales.
Who are Corcym's main competitors?
Broad incumbents on record are Edwards Lifesciences, Medtronic, Abbott and Boston Scientific. Direct peers are LivaNova and Artivion. Emerging players are JenaValve Technology and MicroPort Scientific. Meril Life Sciences is listed as a regional player. AtriCure is listed as an others.
Does Corcym have an API?
No public API is recorded for Corcym.
What industry is Corcym in?
Corcym's product category is Cardiovascular Medical Devices. Its primary akta.pro industry code is HLAHAFAB, Structural Heart Valves (TAVR/SAVR) & Valve Repair, with a secondary code of HLAHAFAH, Cardiac Surgery Devices (Cannulas, Clamps, Closure, Grafts). Its NAICS code is 339113 and its SIC code is 3841.